Cargando…
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway
BACKGROUND: Despite the remarkable progression in colon cancer treatment in recent years, the pathological mechanism underlying this disease remains unclear. This study aimed to discuss the potential of luteolin in the treatment of colon cancer, from the perspective of traditional Chinese medicine,...
Autores principales: | Jiang, Jingwen, Zhu, Fengting, Zhang, Hui, Sun, Tao, Fu, Fangfang, Chen, Xuewu, Zhang, Yanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459197/ https://www.ncbi.nlm.nih.gov/pubmed/36092354 http://dx.doi.org/10.21037/jgo-22-507 |
Ejemplares similares
-
Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway
por: Cummins, Claire B., et al.
Publicado: (2018) -
Luteolin alleviated neutrophilic asthma by inhibiting IL-36γ secretion-mediated MAPK pathways
por: Qiao, Xin-rui, et al.
Publicado: (2023) -
Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL-6/STAT3 signaling pathway
por: Shi, Wei, et al.
Publicado: (2021) -
Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway
por: Zhang, Chuan, et al.
Publicado: (2019) -
Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model
por: Palombo, R, et al.
Publicado: (2016)